Revive Therapeutics Expands Bucillamine Research to Treat Omicron Variant and Adds Inflammatory Markers to FDA Phase 3… Dec 3, 2021
Former Peloton Executive Vicki Reed Is Field Trip Health’s Newly Appointed Chief Growth Officer Dec 2, 2021
Revitalist’s Kathryn Walker On Psychedelics & Their Potential To Upend Traditional Medicine Dec 2, 2021
Tryp Therapeutics Receives Confirmation from FDA to Proceed with Phase 2a Study in Fibromyalgia Dec 2, 2021
